Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Article - 15/10/2012 18357_de.jpg

    ERC Starting Grants 2012: Baden-Württemberg achieves above-average success

    On September 10th 2012, the European Research Council (ERC) announced the results of the fifth funding round of its Starting Grants. Baden-Württemberg was awarded 13 grants, and is the state with the largest number of a total of 34 grants awarded to German life sciences researchers. Baden-Württemberg life sciences researchers will be receiving Starting Grants worth around 20 million euros.

    https://www.gesundheitsindustrie-bw.de/en/article/news/erc-starting-grants-2012-baden-wuerttemberg-achieves-above-average-success
  • Article - 27/06/2011 The photo shows a magnetic resonance image of a human head. A walnut-size structure can be seen inside the brain.

    New therapeutic approaches: nitric oxide for the treatment of brain tumours

    Researchers led by neurosurgeon Dr. Astrid Weyerbrock from the Freiburg University Medical Centre are working on the improvement of therapies for the effective treatment of glioblastomas that involve deciphering the biological mechanisms that lead to these complex brain tumours. They are using a volatile molecule that is also found in the earths atmosphere.

    https://www.gesundheitsindustrie-bw.de/en/article/news/new-therapeutic-approaches-nitric-oxide-for-the-treatment-of-brain-tumours
  • Article - 27/04/2009 Roland Eils is professor of bioinformatics at the University of Heidelberg and the German Cancer Research Centre. In addition, he is one of the founding directors of the systems biology centre BIOQUANT.

    Roland Eils – a mathematician surrounded by molecular biologists

    Not that long ago the Mathematical Faculty of the University of Heidelberg rejected his doctoral thesis but now Roland Eils is professor at the very same faculty. The mathematician whose doctoral thesis was ahead of its time and his two research groups at the University of Heidelberg and the German Cancer Research Centre DKFZ work in the fields of systems biology and oncology. Eils is also one of three founding directors of the systems biology…

    https://www.gesundheitsindustrie-bw.de/en/article/news/roland-eils-a-mathematician-surrounded-by-molecular-biologists
  • Article - 06/06/2011 14480_de.jpg

    Review: “DKFZ-ZMBH Alliance Forum on Aging & Cancer” in Heidelberg

    At the DKFZ-ZMBH Alliance Forum 2011 recently held in Heidelberg internationally leading molecular and cell biologists cancer researchers and epidemiologists presented their latest results on the ageing of cells and organisms and the development of cancer.

    https://www.gesundheitsindustrie-bw.de/en/article/news/review-dkfz-zmbh-alliance-forum-on-aging-cancer-in-heidelberg
  • Article - 30/06/2014 21541_de.jpg

    The German National Cohort: collecting data for a healthier future

    A large-scale long-term cohort study will be carried out to explain the causes of widespread diseases, in particular cancer, coronary heart disease, stroke and diabetes, and to identify the risk factors that lead to or favour the development of a certain disease. The principal objective of the German National Cohort (GNC) is to create the conditions that enable the development of new strategies for the prevention, risk assessment and early…

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-german-national-cohort-collecting-data-for-a-healthier-future
  • Article - 14/06/2010 11507_de.jpg

    Promoters for the construction of genetic circuits

    Gene switches or promoters are crucially important for the regulation of all cellular activities and thus play a pivotal role for researchers constructing externally controllable genetic circuits using synthetic biology methods. The most common artificial regulatory system uses the Tet technology and tetracycline-sensitive promoters invented by Bujard and his team.

    https://www.gesundheitsindustrie-bw.de/en/article/news/promoters-for-the-construction-of-genetic-circuits
  • Database entry

    HiSS Diagnostics GmbH

  • Article - 10/07/2010 The schematic shows the two mitochondrial membranes and the protein import and sorting machinery in and around them.

    Membrane proteins and the import business of mitochondria

    The powerhouses of cells are surprisingly dependent on external help. More than ninety per cent of all proteins required by the mitochondria are produced outside the outer mitochondrial membrane. How are these proteins transported across the membrane and how do they find their way into the mitochondria? A group of researchers led by Prof. Dr. Chris Meisinger at the University of Freiburg has been investigating the role of large protein complexes…

    https://www.gesundheitsindustrie-bw.de/en/article/news/membrane-proteins-and-the-import-business-of-mitochondria
  • Article - 07/11/2008

    Living cells in focus

    Prof. Christoph Cremer Cremer hopes to use the Vertico-SMI nanoscope to decipher the molecular secrets of cells. After the 4Pi microscopy this system is the second development of his scientific career to break through the barrier of optical microscopy.

    https://www.gesundheitsindustrie-bw.de/en/article/news/living-cells-in-focus
  • Article - 19/08/2013 Samples required for whole-genome sequencing are now becoming smaller and smaller. Photo showing a sample tube and coloured letters of the DNA constituents GATC in the background.<br />

    The Heidelberg practice of whole-genome sequencing

    After two years’ work, scientists from Heidelberg have now presented their opinion on the ethical and legal consequences of the total sequencing of the human genome. The paper presents principles and practical recommendations aimed at maintaining the balance between the wellbeing and interests of patients on the one hand and the freedom of research and clinical progress on the other.

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-heidelberg-practice-of-whole-genome-sequencing
  • Dossier - 05/10/2011 15491_de.jpg

    Biosimilars: follow-on biologics of innovator biopharmaceutical products

    As blockbuster biopharmaceuticals go off patent, biosimilars are increasingly competing with them for a market share. However, the production of biosimilars is rather complex and costly. The approval of biosimilars is also subject to many hurdles. Their introduction to the very expensive biopharmaceuticals market is often associated with marginal price reductions.

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/biosimilars-follow-on-biologics-of-innovator-biopharmaceutical-products
  • Article - 09/10/2019 Der Kopf eines Wissenschaftlers vor einem Computerbildschirm mit Molekülmodell.

    Epigenomics from the Cyber Valley

    Cyber Valley Stuttgart-Tübingen is a European hotspot for artificial intelligence and home to many renowned experts and scientists. They are now joined by Gabriele Schweikert, who heads up the Computational Epigenomics research group in the Cyber Valley’s Division of Computational Biology. Schweikert is interested in exploring epigenetic mechanisms using machine learning methods.

    https://www.gesundheitsindustrie-bw.de/en/article/news/epigenomik-aus-dem-cyber-valley
  • Database entry

    ORPEGEN Peptide Chemicals GmbH

  • Dossier - 12/03/2012 16658_de.jpg

    Regenerative medicine makes use of patients’ own resources

    Regenerative medicine offers new therapeutic options for many diseases in which organ function or structure are damaged or lost. The majority of regenerative therapies involve cell-based methods that are often combined with innovative biomaterials. Regenerative therapies combine know-how from the biosciences with state-of-the-art medical technology and also benefit from progress in the engineering and material sciences.

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/regenerative-medicine-makes-use-of-patients-own-resources
  • Article - 21/02/2008

    The inversion of the dorsoventral axis in the separation of Bilataria

    The basic classification of bilateral animals is based on the comparison of their embryonic development and was confirmed in modern molecular phylogeny by the analysis of the relationship of the genes involved. Conserved groups of genes are responsible for the formation of the body axes.

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-inversion-of-the-dorsoventral-axis-in-the-separation-of-bilataria
  • Article - 16/12/2009

    BioValley “Science meets Business Day 2009”

    This year’s presentations at the “Science meets Business Day 2009” once again showed that the exchange between science and the industry in the BioValley works extraordinarily well. The “Science meets Business Day 2009” concluded this year’s BioValley Life Science Week, where researchers from five completely different disciplines and their industrial partners presented their views on what makes the economic location in the area bordered by…

    https://www.gesundheitsindustrie-bw.de/en/article/news/biovalley-science-meets-business-day-2009
  • Article - 13/03/2010 10874_de.jpg

    Assembling life from building blocks?

    As part of its “Bioethics Forum”, the German Ethics Council recently held a meeting in Berlin to inform the public about the fundamentals of synthetic biology and potential ethical problems and consequences in terms of our ideas about life and mankind in general arising from the progress made in this new field of research.

    https://www.gesundheitsindustrie-bw.de/en/article/news/assembling-life-from-building-blocks
  • Article - 04/04/2011 14053_de.jpg

    FreiBiotics GmbH – new drugs against resistant bacteria

    Bacteria adapt quickly to their environment and also to antibiotics. Many of the antibiotics used to treat bacterial infections have become ineffective as a great many bacteria have become resistant to them. Freiburg-based FreiBiotics GmbH is looking for completely new classes of antimicrobial substances. A screening method that has been developed over the last few years based on biosensors makes the identification of new substance classes more…

    https://www.gesundheitsindustrie-bw.de/en/article/news/freibiotics-gmbh-new-drugs-against-resistant-bacteria
  • Article - 28/11/2008

    Skin might be able to close the translation gap

    Karin Scharffetter-Kochanek dermatologist and head of the Department of Dermatology and Allergology at the University Hospital of Ulm has spent a long time investigating skin ageing. Her specific focus on skin has not however restricted her understanding of ageing to barely deterministic or mechanistic details. Quite the opposite is true.

    https://www.gesundheitsindustrie-bw.de/en/article/news/skin-might-be-able-to-close-the-translation-gap
  • Article - 19/11/2009 Prof. Iwona Adamska and biologist Jens Lohscheider working at a clean bench in the laboratory

    Iwona Adamska helps plants exposed to light stress

    Light is a vital element for plants. They require light to carry out photosynthesis and to produce their body substance from inorganic substances such as water and carbon dioxide. On the other hand plants can also suffer from too much light. Plants have developed a number of protective mechanisms to survive light stress situations. The biologist Prof. Iwona Adamska from the University of Constance is looking closely into these protective…

    https://www.gesundheitsindustrie-bw.de/en/article/news/iwona-adamska-helps-plants-exposed-to-light-stress
  • Press release - 17/10/2008

    From protein complex to network

    “In order to fully understand an organism, it is necessary to consider it as a whole,” said Dr. Uwe Schulte, biochemist and CEO of Logopharm GmbH in Freiburg. A growing number of scientists hold the same view, and there is a growing inclination to research the big picture. This is reflected in the continuously increasing number of projects looking into systems biology research.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/from-protein-complex-to-network
  • Article - 01/02/2018 The photo shows the dentate gyrus of a rat (part of the hippocampus). The nuclei of the nerve cells that run like a ribbon from the left-hand to the right-hand side of the photo, are stained red; immature, newly formed nerve cells are white.

    Combined test systems to advance the development of drugs for treating Alzheimer’s

    Which substances are suitable for treating neurodegenerative diseases such as Alzheimer's? Due to complex biochemical relationships, testing suitable drug candidates is difficult, especially in the early drug development phase. Many predictive test systems only cover individual aspects. A team from Baden-Württemberg and France is now combining different models to develop a new approach.

    https://www.gesundheitsindustrie-bw.de/en/article/news/combined-test-systems-to-advance-the-development-of-drugs-for-treating-alzheimers
  • Database entry

    Boehringer Ingelheim Pharma GmbH & Co. KG

  • Article - 25/01/2010 Prof. Dr. Martin Elmlinger and his colleague Marion Eisenhauer in the laboratory. Elmlinger is holding a ball-pen in his hand, pointing at a microtitre plate Marion Eisenhauer is holding in her hand.<br />

    Intelligent use of suitable biomarkers

    How quickly does a pharmaceutical substance exert its effect? What mechanisms does it use to exert its effect on people and how long does it remain active? In a team headed by Prof. Dr. Martin Elmlinger Nycomed GmbH has developed an efficient biomarker discovery concept specially adapted to the companys requirements and designed to clarify such questions. The concept is specifically geared to the phases and requirements of the companys projects.…

    https://www.gesundheitsindustrie-bw.de/en/article/news/intelligent-use-of-suitable-biomarkers
  • Press release - 30/09/2008

    Harald Krug is investigating the use of new materials

    Prof. Dr. Harald Krug a toxicologist who runs the Materials-Biology Interaction division at Empa - Swiss Federal Laboratories for Materials Testing and Research in St. Gallen Switzerland and his team are investigating the interactions of synthetic materials with biological systems. The team of 25 researchers is focusing in particular on the effect of particles and nanomaterials such as CNT on human and animal cells. The division has been an…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/harald-krug-is-investigating-the-use-of-new-materials

Page 15 / 17

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • eine Seite zurück
  • Extend search to all portals
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2019 BIOPRO Baden-Württemberg
Website address: https://www.gesundheitsindustrie-bw.de/en/search